Study of AMV564 in Patients With AML
Clinical trial NCT03144245 · COMPLETED
Trial details
- NCT number
- NCT03144245
- Sponsor
- Amphivena Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2020-07-21
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.